Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
icosapent ethyl (vascepa) (2 trials)
sulfur hexafluoride lipid-type a microspheres (Lumason) (1 trial)
insulin aspart (Novolog) (1 trial)
insulin human (humulin) (1 trial)
insulin lispro (humalog) (1 trial)
l-glutamine (1 trial)
Anemia, Sickle Cell (Phase 2)
Hypertriglyceridemia (Phase 3)
Trials (5 total)
Trial APIs (6 total)